- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06847880
The Potential Effect of the Local Administration of Vitamins C and E on Orthodontic Treatment: A Randomized Clinical Trial
Brief Summary of the Study
This study investigates the effects of locally administered vitamins C and E on orthodontic tooth movement during the initial stage of treatment. Orthodontic tooth movement relies on bone remodeling, which can be influenced by antioxidants like vitamins C and E. Vitamin C promotes collagen formation and osteoblast activity, while vitamin E has anti-inflammatory and antioxidant properties that may impact bone metabolism.
The study is a randomized clinical trial conducted in multiple clinics, where patients will be divided into three groups:
- Control group - receives a saline injection.
- Vitamin C group - receives a local injection of vitamin C.
- Vitamin E group - receives a local injection of vitamin E.
Injections will be administered every two weeks for vitamin C and every month for vitamin E, for six months, while patients undergo orthodontic treatment with fixed appliances. Researchers will evaluate the rate of tooth movement, root resorption, pain perception, and patient experience. Additionally, biomarkers related to bone remodeling will be measured in gingival crevicular fluid at different time points.
The study aims to determine whether local administration of vitamins C or E enhances orthodontic tooth movement and elevate their effects on the orthodontic potential side effects like root resorption and pain. The findings may provide valuable insights into optimizing orthodontic treatment with the help of antioxidants.
Study Overview
Status
Intervention / Treatment
Detailed Description
This randomized clinical trial aims to investigate the effects of locally administered vitamins C and E on mandibular incisor crowding relief during the initial stage of orthodontic treatment. The study follows a multicenter, prospective, single-blinded, parallel-group design with equal randomization (1:1) and is conducted in private clinics and hospitals.
Study Rationale
Orthodontic tooth movement involves a complex biological process mediated by bone remodeling, which is regulated by mechanical forces and biochemical mediators. Oxidative stress and inflammatory responses play a significant role in the remodeling process. Vitamin C (ascorbic acid) and vitamin E (tocopherol) are known for their antioxidant properties and potential effects on bone metabolism, tissue healing, and inflammation modulation. This study aims to determine whether locally administered vitamins C and E can enhance orthodontic tooth movement, reduce adverse effects such as root resorption, and improve patient experience during treatment.
Study Objectives
The primary objective is to compare the effectiveness of vitamin C and vitamin E injections versus a saline control in mandibular incisor crowding relief over 24 weeks.
The secondary objectives include:
- Assessing the extent of apical root resorption using periapical radiographs.
- Evaluating pain perception using a Visual Analog Scale (VAS) during the first week after each archwire change.
- Measuring patient perception of treatment experience through a structured questionnaire.
- Analyzing levels of biomarkers associated with bone remodeling (RANKL, OPG, RUNX2) in gingival crevicular fluid (GCF) to determine the biological effects of the interventions.
Participant Selection
Eligible participants are patients aged 12 years and older with moderate to very severe mandibular anterior crowding (Little's Irregularity Index [LII]). Exclusion criteria include systemic diseases, prior orthodontic treatment, or the use of medications that could influence bone metabolism or inflammatory responses.
Intervention Groups
Participants will be randomly assigned to one of three groups:
- Control Group: Receives saline injection.
- Vitamin C Group: Receives intraepidermal injection of vitamin C (120 mg in 1.2 ml, divided among six mandibular anterior teeth).
- Vitamin E Group: Receives intraepidermal injection of vitamin E (15mg in 0.1 ml, divided among six mandibular anterior teeth).
Injections are repeated biweekly for vitamin C and monthly for vitamin E, for a total of six months (24 weeks).
Orthodontic Treatment Protocol
All participants undergo standardized orthodontic treatment using MBT brackets (0.022-inch slot). The leveling and alignment phase follows a sequential archwire progression with CuNiTi archwires in the following sequence:
- 0.014-inch CuNiTi (initial 4 weeks)
- 0.016-inch CuNiTi (weeks 4-8)
- 0.018-inch CuNiTi (weeks 8-24)
No additional orthodontic interventions, such as interproximal reduction or extractions, will be performed during the study period.
Data Collection and Outcome Assessments
Data will be collected at multiple time points throughout the study:
Mandibular Incisor Crowding Relief
- 3D-scanned digital models will be used to measure Little's Irregularity Index (LII) at baseline and every 4 weeks until week 24.
Root Resorption
- Standardized periapical radiographs of mandibular anterior teeth will be taken at baseline, 8 weeks, and 24 weeks to evaluate root resorption.
Pain Perception
- Participants will record pain intensity on a VAS scale (0-10) during the first week after each wire change (every 4 weeks).
Patient Perception
- A structured questionnaire assessing comfort, esthetics, and perceived treatment progress will be administered at 8 weeks.
Biomarker Analysis
- Gingival crevicular fluid (GCF) samples will be collected at baseline, 1 week, and 4 weeks. Levels of RANKL, OPG, and RUNX2 will be analyzed to assess changes in bone remodeling activity.
Statistical Analysis
Data will be analyzed using SPSS v26.Statistical methods include:
- Descriptive statistics (mean, standard deviation, frequency).
- Reliability analysis for measurement consistency.
- Inferential statistics, including paired and independent t-tests, analysis of variance (ANOVA), and regression models, to compare treatment effects.
A significance level of 0.05 will be used for hypothesis testing.
Study Oversight and Ethical Considerations
The study is self-funded and complies with ethical guidelines for human research. Ethical approval is pending from the appropriate review board. All participants (or their legal guardians) will provide informed consent before enrollment.
Potential Impact
This trial may provide valuable insights into the role of antioxidant therapy in orthodontic treatment. If vitamins C and E positively influence tooth movement and root integrity, their use could enhance treatment efficiency while minimizing complications. Findings may also contribute to a better understanding of bone remodeling mechanisms in response to mechanical forces.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Baghdad Governorate
-
Baghdad, Baghdad Governorate, Iraq, 10013
- Baghdad Al-Karkh Health Directorate, Baghdad, Iraq
-
Baghdad, Baghdad Governorate, Iraq, 10061
- Baghdad Al-Rusafa Health Directorate
-
Baghdad, Baghdad Governorate, Iraq, 10071
- College of Dentistry, University of Baghdad, Baghdad, Iraq
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients aged 12 years and above, who are indicated for fixed appliance orthodontic treatment.
- Patients with moderate to very severe crowding of the mandibular anterior teeth as per the Little's Irregularity Index (LII).
- Treatment with or without two mandibular first premolars extraction. Presence of all the mandibular permanent teeth, except the third molars.
5. The overbite and overjet should not impede bracket placement on the mandibular anterior teeth.
Exclusion Criteria:
- History of previous orthodontic intervention.
- History of trauma or root resorption in the mandibular anterior teeth.
- Presence of mandibular anterior teeth crowding of less than 4 mm (LII).
- Existence of blocked-out teeth precluding engagement with the aligning archwire.
- History of systemic diseases, especially diabetes and bone diseases.
- Patients with periodontitis and obvious loss of tooth attachment according to Plaque and Bleeding on Probing indices.
- Pregnant and lactating mothers.
- Mouth breathing patients and smokers.
- Healthy patients who have not used any medications (such as anti-inflammatory or antimicrobial drugs) or supplements (such as vitamins)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm 1: Vitamin C Treatment
This arm involves participants receiving Vitamin C to assess its effect on orthodontic tooth movement and crowding relief.
The treatment aims to evaluate how Vitamin C influences the rate of tooth movement, as measured by Little's Irregularity Index (LII) over 24 weeks (the supposed end date of leveling and alignment stage).
|
• Vitamin C (Ascorbic Acid): This intervention involves the administration of vitamin C, which is known for its antioxidant properties.
The concentration will be 120 mg in 1.2 ml, and the produced volume will be divided by six lower anterior teeth; each tooth will receive 0.2 ml (20 mg) of the vitamin C. It is hypothesized to accelerate orthodontic tooth movement by reducing oxidative stress and promoting collagen synthesis.
|
|
Experimental: Vitamin E Treatment
Participants in this arm will receive Vitamin E to evaluate its effect on orthodontic tooth movement.
The aim is to compare the efficacy of Vitamin E to Vitamin C and the saline control in terms of crowding relief and tooth alignment, measured using LII over a 24-week period (the supposed end date of leveling and alignment stage).
|
• Vitamin E (Tocopherol Acetate): This intervention uses vitamin E, another antioxidant, thought to reduce inflammation and support tissue repair, potentially improving the effectiveness of orthodontic treatment by enhancing tissue recovery and reducing side effects.
The concentration will be 60 mg in 0.4 ml, and the produced volume will be divided by six lower anterior teeth; each tooth will receive 0.07 ml (10 mg) of the vitamin E.
|
|
Placebo Comparator: Arm 3: Saline Control
This arm serves as the control group, where participants receive saline injections.
The primary aim is to assess how saline compares with Vitamin C and Vitamin E treatments in terms of the rate of orthodontic tooth movement and crowding relief as measured by LII.
|
Saline Solution (Control): The control group will receive a saline solution, which is a placebo, allowing for the comparison of the effects of vitamin C and vitamin E on orthodontic tooth movement without the influence of additional nutrients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in the amount of crowding relief of the mandibular incisors before treatment and at 4, 8, 12, 16, 20, and 24 weeks after the start of treatment among the two vitamins and control groups
Time Frame: The amount of crowding relief will be measured using Little's Irregularity Index (LII) on 3D digital models of the mandibular anterior teeth. Measurements will be taken at baseline (T0) and at 4, 8, 12, 16, 20, and 24 weeks to assess changes over time.
|
The amount of crowding relief will be measured using Little's Irregularity Index (LII) on 3D digital models of the mandibular anterior teeth. Pre-treatment (T0) and post-treatment models at 4, 8, 12, 16, 20, and 24 weeks will be compared.
|
The amount of crowding relief will be measured using Little's Irregularity Index (LII) on 3D digital models of the mandibular anterior teeth. Measurements will be taken at baseline (T0) and at 4, 8, 12, 16, 20, and 24 weeks to assess changes over time.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Perception After Archwire Placement: A Visual Analog Scale Assessment
Time Frame: From the placement of each archwire to 7 days post-placement.
|
Pain perception will be measured using a Visual Analog Scale (VAS), a commonly used tool in clinical settings to quantify subjective pain experiences.
The VAS consists of a 10 cm line where participants mark their pain level.
One end of the line represents "no pain" (score of 0), and the other end represents "worst pain imaginable" (score of 10).
Participants will be asked to record their pain levels twice daily for the first 7 days following each archwire placement during the treatment phase.
|
From the placement of each archwire to 7 days post-placement.
|
|
Amount of orthodontically-induced inflammatory root resorption (OIIRR) in the apical region of mandibular anterior teeth
Time Frame: Pre-treatment (T0), 8 weeks (T1), and 24 weeks (T2) after the start of treatment.
|
Measurement of the root resorption in the apical region of the mandibular anterior teeth, assessed through radiographs and calculated by comparing the root length and crown length.
|
Pre-treatment (T0), 8 weeks (T1), and 24 weeks (T2) after the start of treatment.
|
|
Patient perception using a newly developed questionnaire for adjunctive orthodontic therapy
Time Frame: 8 weeks after the start of treatment.
|
Patients will complete a questionnaire to assess their perception of the treatment's comfort, side effects, and any additional effects due to vitamin administration during orthodontic therapy.
|
8 weeks after the start of treatment.
|
|
Levels of biomarkers (RANKL, OPG, and RUNX2) in gingival crevicular fluid (GCF):
Time Frame: Pre-treatment (T0), 1 week (T1), and 4 weeks (T2) after the start of treatment.
|
Measurement of the biomarkers in the GCF, which are involved in bone turnover and remodeling.
These markers will help assess the biological effects of the vitamins on periodontal tissues during the initial stage of orthodontic treatment.
|
Pre-treatment (T0), 1 week (T1), and 4 weeks (T2) after the start of treatment.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Professor Dr. Yassir Abdulkadhim Yassir, Ph.D. (Orthodontics) (UK), University of Baghdad
Publications and helpful links
General Publications
- Bolat E, Esenlik E, Oncu M, Ozgocmen M, Avunduk MC, Yuksel O. Evaluation of the effects of vitamins C and E on experimental orthodontic tooth movement. J Dent Res Dent Clin Dent Prospects. 2020 Spring;14(2):131-137. doi: 10.34172/joddd.2020.0027. Epub 2020 Jun 17.
- Yussif, N. (2019). Oral Mesotherapy: might be considered as an adjunctive technique for the different surgical procedures?. In Periodontal disease-diagnostic and adjunctive non-surgical considerations. IntechOpen.
- Yussif, N.M.A., Dehis, H.M., Rahman, A.R.A., Aziz, M.A.W.M.A. and Yassin, M.M. (2018). Efficacy and safety of locally injectable vitamin C on accelerating the orthodontic movement of maxillary canine impaction (oral mesotherapy technique): prospective study. Clinical Cases in Mineral & Bone Metabolism, 15(2).
- Mohsin MK, Qadir Omer Z. The effect of vitamin E incorporated into injectable platelet-rich fibrin on orthodontic tooth movement in rabbits. Cell Mol Biol (Noisy-le-grand). 2024 Jun 5;70(6):147-154. doi: 10.14715/cmb/2024.70.6.23.
- Kappus H, Diplock AT. Tolerance and safety of vitamin E: a toxicological position report. Free Radic Biol Med. 1992;13(1):55-74. doi: 10.1016/0891-5849(92)90166-e.
- Esenlik E, Naziroglu M, Acikalin C, Ovey IS. Vitamin E supplementation modulates gingival crevicular fluid lipid peroxidation and antioxidant levels in patients with orthodontic tooth movement. Cell Biochem Funct. 2012 Jul;30(5):376-81. doi: 10.1002/cbf.1833. Epub 2011 Nov 24.
- Carr AC, Lykkesfeldt J. Discrepancies in global vitamin C recommendations: a review of RDA criteria and underlying health perspectives. Crit Rev Food Sci Nutr. 2021;61(5):742-755. doi: 10.1080/10408398.2020.1744513. Epub 2020 Mar 30.
- Mucklow, J.C. (2000). Martindale: the complete drug reference. British journal of clinical pharmacology, 49(6), p.613.
- Hathcock JN, Azzi A, Blumberg J, Bray T, Dickinson A, Frei B, Jialal I, Johnston CS, Kelly FJ, Kraemer K, Packer L, Parthasarathy S, Sies H, Traber MG. Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr. 2005 Apr;81(4):736-45. doi: 10.1093/ajcn/81.4.736.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1014425
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Biomarkers
-
Fu Jen Catholic University HospitalRecruitingPerimenopausal Biomarkers | Mitochondrial BiomarkersTaiwan
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedNutrition, Biomarkers of Intake, Urinary Biomarkers, Foodomics, MetabolomMexico
-
Peking UniversityCompleted
-
University of California, DavisUSDA, Western Human Nutrition Research CenterCompleted
-
Harvard School of Public Health (HSPH)CompletedBiomarkersUnited States
-
University of MinnesotaCompleted
-
West China HospitalRecruitingBiomarkers | NeonateChina
-
U.S. Army Medical Research and Development CommandWalter Reed Army Institute of Research (WRAIR)CompletedBiomarkers, PharmacologicalUnited States
-
Eman Ashraf Saad AhmedNot yet recruiting
-
Pirogov Russian National Research Medical UniversityRecruitingBiomarkers | Healthy AgingRussia
Clinical Trials on 1: Vitamin C Supplementation
-
University of GlasgowProfessor Konstantinos Gerasimidis, University of GlasgowRecruitingGut Microbiota Diversity and Composition | Short Chain Fatty Acids Concentration in StoolsUnited Kingdom
-
Institut de Recherches Cliniques de MontrealUniversité de MontréalWithdrawnCystic FibrosisCanada
-
Institut de Recherche en Sciences de la Sante,...Active, not recruitingMalaria | Malnutrition, ChildBurkina Faso
-
National Taiwan University HospitalUnknownAtrophic Glossitis, Burning Mouth SyndromeTaiwan
-
IIMC, Riphah International University, PakistanNot yet recruitingGestational Diabetes MellitusPakistan
-
Wageningen UniversityZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedCognitive Decline | Cognitive SymptomsNetherlands
-
University of Sao PauloEnrolling by invitationOverweight and Obesity | Lupus ErythematosusBrazil
-
Qualia Life SciencesCompleted
-
Medical University of BialystokLomza State University of Applied Sciences; International Science & Health... and other collaboratorsRecruitingVitamin D3 | Fracture Healing | Deficiency of Vitamin K2Poland